SB-300, Jaguar's Drug Product Candidate for the Treatment of Gastric Ulcers, Enables Continued Therapy in Performance Horses in Accordance with Standard Testing Guidelines

Results of Initial Study Show that Jaguar's Equine Product Candidate for Treatment of Gastric Ulcers May Offer Horse Owners an Additional Advantage in the Competition Horse World, where Requirements Exist for Animals to Compete Free from the Effect of Any Drugs

Sign up for our free eNews letter. We do not share our list and we send one per week. Select any of the topics below.

Friday

December 15, 2017

Sorry, no events.

Saturday

December 16, 2017

Sorry, no events.

Sunday

December 17, 2017

Sorry, no events.

Monday

December 18, 2017

Sorry, no events.

Tuesday

December 19, 2017

Sorry, no events.

Wednesday

December 20, 2017

Sorry, no events.

Thursday

December 21, 2017

Sorry, no events.

Ad for Issue 112